PURPOSE: This study aimed to compare medium-term functional effects of three different treatment modalities in @entity1 with @entity75 of the talus (OLT). METHODS: Fifty-four @entity1 undergoing arthroscopic surgery for osteochondral lesion of the talus were included in this study. @entity1 were assigned to one of the three treatment groups: microfracture surgery (n  =  19), microfracture surgery plus platelet-rich plasma (PRP) (n  =  22), and mosaicplasty (n  =  13). Function was assessed using the @entity3681 ( @entity3681 ) scoring system and VAS scores for @entity158 , before and after surgery. In addition, the Foot and Ankle Ability Measure (FAAM) tests for @entity158 and 15-min walking were done at follow-up visits. RESULTS: The median duration of follow-up was 42  months (range 12-84  months). All groups showed significant improvements in @entity3681 and VAS @entity158 scores at the last follow-up visit, when compared to baseline. The groups did not differ with regard to change in baseline @entity3681 score; however, improvement in VAS @entity158 scores was significantly better in the mosaicplasty group when compared to the microfracture group (change from baseline, -5.8      1.0 vs. -3.2      2.9, p  =  0.018). CONCLUSIONS: All the three treatment modalities resulted in good medium-term functional results. However, mosaicplasty procedure seems to be a promising option and it might be preferred particularly in @entity1 where @entity158 control is important. LEVEL OF EVIDENCE: II.

Medium-term outcomes of mosaicplasty versus arthroscopic microfracture with or without platelet-rich plasma in the treatment of XXXX of the talus.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity75 :: ('MESH:D001927', 'Disease') :: ['osteochondral lesions'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity3681 :: ('MESH:D016512', 'Disease') :: ['American Orthopedic Foot and Ankle Society', 'AOFAS']
@entity75 :: (MESH:D001927,Disease) :: ['osteochondral lesions']
